Federal contractor · NEW TAIPEI CITY

PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.

PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD. received $790.5K in federal contract obligations in FY2026, on 2 awards (+458% vs FY2025). Since FY2018: $11.4M. Its largest customer was National Institutes of Health ($790.5K).

Obligations · FY2026
$790.5K
New awards
2
Sole-source
0.0%
Single offer
0.0%
UEI
MXP1NVQ8C1J8
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 1.9MFY2018
  2. 1.3MFY2019
  3. 1.3MFY2020
  4. 1.5MFY2021
  5. 1.6MFY2022
  6. 1.6MFY2023
  7. 1.3MFY2024
  8. 141.7KFY2025
  9. 790.5KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$790.5K100%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$790.5K100%

Where the work was performed

  1. Abroad$621.3K79%
  2. Montgomery County, MD$169.2K21%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. MOUSE MODEL OF NEISSERIA GONORRHOEAE INFECTION$621.3K
    National Institutes of Health· Research & development· Jul 21, 2026 – Jul 21, 2026· 75N93026F00002
  2. A12 - MURINE MODELS OF UTI INFECTION CAUSED BY ANTIBIOTIC-RESISTANT BACTERIA$169.2K
    National Institutes of Health· Montgomery County, MD· Research & development· Apr 16, 2026 – Apr 16, 2026· 75N93026F00001

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. NEOVAXSYN INC$2.3M
    AMES, IA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. INNOVATION PATHWAYS, LLC$2.1M−78% in FY2026
    PALO ALTO, CA · 94% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. DOSEOPTICS LLC$2.4M−100% in FY2026
    LEBANON, NH · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.